<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>66</volume><submitter>Cercillieux A</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Disturbances in NAD&lt;sup>+&lt;/sup> metabolism have been described as a hallmark for multiple metabolic and age-related diseases, including type 2 diabetes. While alterations in pancreatic β-cell function are critical determinants of whole-body glucose homeostasis, the role of NAD&lt;sup>+&lt;/sup> metabolism in the endocrine pancreas remains poorly explored. Here, we aimed to evaluate the role of nicotinamide riboside (NR) metabolism in maintaining NAD&lt;sup>+&lt;/sup> levels and pancreatic β-cell function in pathophysiological conditions.&lt;h4>Methods&lt;/h4>Whole body and pancreatic β-cell-specific NRK1 knockout (KO) mice were metabolically phenotyped in situations of high-fat feeding and aging. We also analyzed pancreatic β-cell function, β-cell mass and gene expression.&lt;h4>Results&lt;/h4>W</pubmed_abstract><journal>Molecular metabolism</journal><pagination>101605</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9557729</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure.</pubmed_title><pmcid>PMC9557729</pmcid><pubmed_authors>Joffraud M</pubmed_authors><pubmed_authors>Zollinger A</pubmed_authors><pubmed_authors>Jacot G</pubmed_authors><pubmed_authors>Canto C</pubmed_authors><pubmed_authors>Metairon S</pubmed_authors><pubmed_authors>Ciarlo E</pubmed_authors><pubmed_authors>Ratajczak J</pubmed_authors><pubmed_authors>Giroud-Gerbetant J</pubmed_authors><pubmed_authors>Cercillieux A</pubmed_authors><pubmed_authors>Valera-Alberni M</pubmed_authors><pubmed_authors>Sambeat A</pubmed_authors><pubmed_authors>Rumpler M</pubmed_authors><pubmed_authors>Sanchez-Garcia JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure.</name><description>&lt;h4>Objective&lt;/h4>Disturbances in NAD&lt;sup>+&lt;/sup> metabolism have been described as a hallmark for multiple metabolic and age-related diseases, including type 2 diabetes. While alterations in pancreatic β-cell function are critical determinants of whole-body glucose homeostasis, the role of NAD&lt;sup>+&lt;/sup> metabolism in the endocrine pancreas remains poorly explored. Here, we aimed to evaluate the role of nicotinamide riboside (NR) metabolism in maintaining NAD&lt;sup>+&lt;/sup> levels and pancreatic β-cell function in pathophysiological conditions.&lt;h4>Methods&lt;/h4>Whole body and pancreatic β-cell-specific NRK1 knockout (KO) mice were metabolically phenotyped in situations of high-fat feeding and aging. We also analyzed pancreatic β-cell function, β-cell mass and gene expression.&lt;h4>Results&lt;/h4>W</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-22T02:14:12.654Z</modification><creation>2025-04-05T20:21:08.597Z</creation></dates><accession>S-EPMC9557729</accession><cross_references><pubmed>36165811</pubmed><doi>10.1016/j.molmet.2022.101605</doi></cross_references></HashMap>